KCP
DXCM icon

Kera Capital Partners’s DexCom DXCM Stock Holding History

Kera Capital Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Buy
5,333
+1,183
+29% +$78.8K 0.03% 425
2026
Q1 		$261K Buy
4,150
+122
+3% +$8.5K 0.03% 469
2025
Q4 		$294K Buy
+4,028
New +$260K 0.04% 413

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Kera Capital Partners's DXCM Position: Q2 2026 in Review

Kera Capital Partners increased its DexCom (DXCM) stake by 29% in Q2 2026, buying an estimated $78.8K and bringing the position to 5,333 shares worth $359K. The position accounts for 0.03% of the portfolio, ranked #425.

Kera Capital Partners first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Kera Capital Partners held 5,333 shares of DexCom worth $359K as of Q2 2026.
  • Kera Capital Partners bought 1,183 DexCom shares in Q2 2026, an estimated $78.8K.
  • DexCom made up 0.03% of Kera Capital Partners's portfolio in Q2 2026, its #425 holding.
  • Kera Capital Partners first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.